rdf:type |
|
lifeskim:mentions |
umls-concept:C0001175,
umls-concept:C0001857,
umls-concept:C0019682,
umls-concept:C0035525,
umls-concept:C0087111,
umls-concept:C0205210,
umls-concept:C0205374,
umls-concept:C0301625,
umls-concept:C0332281,
umls-concept:C0439855,
umls-concept:C0596873,
umls-concept:C0920321,
umls-concept:C1882534,
umls-concept:C2349975
|
pubmed:issue |
5
|
pubmed:dateCreated |
1987-11-20
|
pubmed:abstractText |
To assess safety, tolerance, and the clinical and laboratory effects of oral ribavirin in patients with the acquired immunodeficiency syndrome (AIDS) and the AIDS-related complex.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0003-4819
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
107
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
664-74
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:3662279-AIDS-Related Complex,
pubmed-meshheading:3662279-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:3662279-Adult,
pubmed-meshheading:3662279-Drug Evaluation,
pubmed-meshheading:3662279-HIV,
pubmed-meshheading:3662279-Hematocrit,
pubmed-meshheading:3662279-Humans,
pubmed-meshheading:3662279-Lymphocyte Activation,
pubmed-meshheading:3662279-Male,
pubmed-meshheading:3662279-Opportunistic Infections,
pubmed-meshheading:3662279-Ribavirin,
pubmed-meshheading:3662279-Ribonucleosides
|
pubmed:year |
1987
|
pubmed:articleTitle |
Ribavirin treatment of the acquired immunodeficiency syndrome (AIDS) and the acquired-immunodeficiency-syndrome-related complex (ARC). A phase 1 study shows transient clinical improvement associated with suppression of the human immunodeficiency virus and enhanced lymphocyte proliferation.
|
pubmed:affiliation |
Divisions of Infectious Diseases, Harvard Thorndike-Dana Research Laboratory, Boston, Massachusetts.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|